Trader Brian Jones on Twitter: "Viveve Announces Primary Efficacy Data From SUI Feasibility Study And Preclinical Outcomes That 'Support the Company's New Sham Tip for Pivotal PURSUIT Trial'(Benzinga)" / Twitter

Viveve Announces Primary Efficacy Data From SUI Feasibility Study And Preclinical Outcomes That 'Support the Company's New Sham Tip for Pivotal PURSUIT Trial'(Benzinga)